Neuland Laboratories has officially launched the first module of its commercial peptide manufacturing facility in Hyderabad, ...

The approved variation enables Upperton to commence GMP manufacture of sterile investigational medicinal products from the purpose-built facility, expanding the company’s integrated development and ...

Shilpa Biologicals Private Limited has entered into an exclusive strategic licensing and commercialization agreement with ...

Of that new CDMO capacity, 71% by volume is large-scale stainless steel, she said, but this is being installed by just a ...

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.

This week on "The Friday Brief," companies put down roots on both sides of the Atlantic, expanding their capabilities in a number of areas.

Shilpa CD MO, a dedicated complex small-molecule contract development and manufacturing organization is launching at CPHI Milan. The new brand, separate from parent company Shilpa Medicare, provides a ...

Additional device assembly and cold storage capabilities strengthen Sharp’s global clinical-to-commercial support for ...